https://www.indianpharmapost.com/rpg-life-sciences-reports-rs-692-crore-pat-in-q4-fy2020-21-84412021-05-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/ajanta-pharma-q4fy21-consolidated-pat-drops-qoq-to-rs-15926-cr-84422021-05-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/biosimilars-performance-below-expectations-for-biocon-icici-direct-84432021-05-03T00:00:00+05:30always0.9https://www.indianpharmapost.com/gujarat-themis-biosyn-q4fy21-net-profit-lower-at-rs-579-cr-84462021-05-03T00:00:00+05:30always0.9